Open access
Oct 2026
Functional redundancy between atypical CDKs reveals a vulnerability in hepatocellular carcinoma.
Findings provide a rationale for the development of CDK16-18 inhibitors-likely targeting multiple subfamily members due to their structural similarity-as a strategy against aggressive cancers, such as hepatocellular carcinoma, where effective treatment options remain limited.
Diego Martínez-Alonso, Enrique Nogueira, Luis R. López-Sainz et al.
· Proceedings of the National... · 0 citations